The EU's generic drug system is changing fast in 2025. Learn how approval pathways, new regulations, and market forces are shaping access to affordable medicines across Europe.
Generic drugs must meet the same safety, strength, and quality standards as brand-name drugs. Learn how the FDA ensures bioequivalence, manufacturing consistency, and patient safety through rigorous testing and inspections.